IBDEI0CY ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5936,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,5937,0)
 ;;=L23.9^^30^385^31
 ;;^UTILITY(U,$J,358.3,5937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5937,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5937,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,5937,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,5938,0)
 ;;=L24.9^^30^385^163
 ;;^UTILITY(U,$J,358.3,5938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5938,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5938,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,5938,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,5939,0)
 ;;=L25.9^^30^385^115
 ;;^UTILITY(U,$J,358.3,5939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5939,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5939,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,5939,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,5940,0)
 ;;=L26.^^30^385^148
 ;;^UTILITY(U,$J,358.3,5940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5940,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,5940,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,5940,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,5941,0)
 ;;=L27.0^^30^385^265
 ;;^UTILITY(U,$J,358.3,5941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5941,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,5941,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,5941,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,5942,0)
 ;;=L27.1^^30^385^266
 ;;^UTILITY(U,$J,358.3,5942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5942,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,5942,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,5942,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,5943,0)
 ;;=L29.0^^30^385^250
 ;;^UTILITY(U,$J,358.3,5943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5943,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,5943,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,5943,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,5944,0)
 ;;=L29.9^^30^385^251
 ;;^UTILITY(U,$J,358.3,5944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5944,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,5944,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,5944,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,5945,0)
 ;;=L30.0^^30^385^232
 ;;^UTILITY(U,$J,358.3,5945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5945,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,5945,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,5945,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,5946,0)
 ;;=L30.1^^30^385^140
 ;;^UTILITY(U,$J,358.3,5946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5946,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,5946,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,5946,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,5947,0)
 ;;=L30.2^^30^385^132
 ;;^UTILITY(U,$J,358.3,5947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5947,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,5947,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,5947,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,5948,0)
 ;;=L30.4^^30^385^144
 ;;^UTILITY(U,$J,358.3,5948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5948,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,5948,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,5948,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,5949,0)
 ;;=L30.8^^30^385^135
 ;;^UTILITY(U,$J,358.3,5949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5949,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,5949,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,5949,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,5950,0)
 ;;=L30.9^^30^385^136
 ;;^UTILITY(U,$J,358.3,5950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5950,1,3,0)
 ;;=3^Dermatitis,Unspec
